The Maryland-based firm said that the money will support the development and commercialization of a screening test for esophageal squamous cell carcinoma.

Morgan Stanley analyst Tejas Savant maintained a Hold rating on Hologic (HOLX – Research Report) today and set a price target of $84.00.

tissues, and the identification of antifungal drug resistance directly from clinical samples. In addition, the recent development of quantitative assays and RNA detection assays further ...

Endometriosis is associated with debilitating pain and increased risk of cancer and autoimmune diseases, yet diagnosis remains out of reach for many patients.

The posters are available on the Posters and Publications page of the Company’s website.

Schistosomiasis is a neglected tropical disease that triggers specific immune responses in the body. Identifying those hidden ...

Researchers investigate the effects of microplastic exposure on the normal aging and function of adipose tissue.

Get article recommendations from ACS based on references in your Mendeley library. Pair your accounts.

Natera (NASDAQ:NTRA – Get Free Report) and Fortrea (NASDAQ:FTRE – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength ...

Rockville, MD, Oct. 21, 2024 (GLOBE NEWSWIRE) -- According to new research report published by Fact.MR, valuation of the ...

Fintel reports that on October 17, 2024, HSBC downgraded their outlook for Qiagen N.V. (NYSE:QGEN) from Buy to Hold. Analyst ...

(2024-10-16 | NDAQ:BIAF) bioAffinity's CyPath® Lung Cancer Test Supported by Newly Published Flow Cytometry Guidelines ...